Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference  
12/9/2010 8:39:08 AM

BUDAPEST, Hungary & MCLEAN, Va.--(BUSINESS WIRE)--Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s HIV DART 2010 conference, “Frontiers in Drug Development for Antiretroviral Therapies,” in Los Cabos, Mexico. The conference brings international researchers together to discuss the latest developments in the fight against HIV/AIDS.